Clinical trial DCC-2618-03-002
A Phase 3, Interventional, Randomized, Multicenter, Open-Label Study of DCC-2618 vs Sunitinib in Patients with Advanced Gastrointestinal Stromal Tumors after Treatment with Imatinib
| Cancers | |
|---|---|
| Organ | Stromal digestive tumors |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 3 |
| Academic trial | Non |
| Sponsor | Deciphera Pharmaceuticals LLC |
| EudraCT Identifier | 2018-001803-35 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03673501 |
| Inclusion criteria | Progression or intolerance to imatinib |
| Last update |